Sangamo Therapeutics

$Sangamo Therapeutics(SGMO)$ 发了招股，以前的权证也要把价格下调，加上之前的资金是不是在埋伏这一次的数据公告？
如果真的招股，这么跌我觉得倒有些机会了，数据看上去就是g3的中风让我有一点担忧，有效性没问题，另外最担心的就是面值退市

$Sangamo Therapeutics(SGMO)$ 洗盘吗？能顺利四月底突破并站稳一刀吗

#药闻简讯# 美国食品药品监督管理局（FDA）已授予 ST-503 快速通道资格，这是一种用于治疗因小纤维神经病变（SFN）引起的难治性疼痛的试验性表观遗传调节剂，小纤维神经病变是一种慢性神经病理性疼痛。$Sangamo Therapeutics(SGMO)$

#药闻简讯# $Sangamo Therapeutics(SGMO)$ 宣布FDA 已接受关于 ST-920（一种用于治疗法布里病的在研基因疗法）的生物制品许可申请 (BLA) 的滚动提交和审查请求。

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002041855-25-000006  Size: 6 KB 网页链接

Sangamo Therapeutics于11月21日宣布，与FDA的会议后，公司获得批准开始BLA的滚动提交，用于其Fabry基因疗法ST-920。这一决定将提交时间提前至2025年第四季度后期，早于原计划的2026年初。ST-920是一种基于AAV载体的基因疗法，旨在通过单次静脉输注递送功能性基因，纠正Fabry病患者缺乏的α-半乳糖...

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001877368-25-000007  Size: 6 KB 网页链接

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002041855-26-000002  Size: 6 KB 网页链接

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001877368-26-000002  Size: 6 KB 网页链接

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001675687-26-000002  Size: 6 KB 网页链接

$Sangamo Therapeutics(SGMO)$ 8-K Current report, items 2.02 and 5.02 Accession Number: 0001001233-26-000002  Act: 34  Size: 146 KB 网页链接

$Sangamo Therapeutics(SGMO)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000814133-25-000099  Act: 34  Size: 6 KB 网页链接

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001947007-26-000002  Size: 6 KB 网页链接

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001779092-26-000002  Size: 6 KB 网页链接

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002089213-26-000002  Size: 6 KB 网页链接

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001675687-25-000008  Size: 6 KB 网页链接

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001779092-25-000007  Size: 6 KB 网页链接

$Sangamo Therapeutics(SGMO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-26-036786  Act: 33  Size: 660 KB 网页链接

$Sangamo Therapeutics(SGMO)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001193125-26-036792  Act: 34  Size: 658 KB 网页链接

$Sangamo Therapeutics(SGMO)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-26-034556  Act: 34  Size: 155 KB 网页链接